SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0    0 The study examined associations between hepatitis C ( HCV ) seropositivity and a lifetime history of jail or correctional facility incarceration among injection drug users .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0    0 The_AT study_NN1 examined_VVD_VVN associations_NN2 between_II hepatitis_NN1 C_ZZ1_NP1 (_Y HCV_NP1 )_Y seropositivity_NN1 and_CC a_AT1 lifetime_NNT1 history_NN1 of_IO jail_NN1 or_CC correctional_JJ facility_NN1 incarceration_NN1 among_II injection_NN1 drug_NN1 users_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0    1 The sample consisted of 351 injection drug users recruited in inner-city neighborhoods of Baltimore .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0    1 The_AT sample_NN1 consisted_VVN_VVD of_IO 351_MC injection_NN1 drug_NN1 users_NN2 recruited_VVN in_II inner-city_JJ neighborhoods_NN2 of_IO Baltimore_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0    2 Multiple logistic regressions were fit to assess associations between HCV seropositivity and a lifetime history of incarceration for the total sample and stratified by race .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0    2 Multiple_JJ logistic_JJ regressions_NN2 were_VBDR fit_JJ to_TO assess_VVI associations_NN2 between_II HCV_NP1 seropositivity_NN1 and_CC a_AT1 lifetime_NNT1 history_NN1 of_IO incarceration_NN1 for_IF the_AT total_JJ_NN1 sample_NN1 and_CC stratified_VVN by_II race_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0    3 Analyses demonstrated HCV nearly two times greater for whites than African Americans .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0    3 Analyses_NN2 demonstrated_VVD_VVN HCV_NP1 nearly_RR two_MC times_NNT2 greater_JJR for_IF whites_NN2 than_CSN African_JJ Americans_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0    4 In addition , HCV was 2.6 times greater in participants incarcerated in correctional facilities and HCV was 7.4 times greater in participants reporting more than 5 years of injection drug use compared to participants reporting less than 1 year of injection drug use .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0    4 In_RR21 addition_RR22 ,_Y HCV_NP1 was_VBDZ 2.6_MC times_NNT2 greater_JJR in_II participants_NN2 incarcerated_VVD_VVN@ in_II_RP@ correctional_JJ facilities_NN2 and_CC HCV_NP1 was_VBDZ 7.4_MC times_NNT2 greater_JJR in_II participants_NN2 reporting_VVG more_DAR than_CSN 5_MC years_NNT2 of_IO injection_NN1 drug_NN1 use_NN1 compared_VVN to_II participants_NN2 reporting_VVG less_DAR_RRR than_CSN 1_MC1 year_NNT1 of_IO injection_NN1 drug_NN1 use_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0    5 The study findings suggest that incorporating systematic HCV screening , prevention , and treatment programs within correctional systems represents a vital yet under-utilized strategy to reduce HCV transmission in society as a whole .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0    5 The_AT study_NN1 findings_NN2 suggest_VV0 that_CST_DD1 incorporating_VVG systematic_JJ HCV_NP1 screening_NN1_VVG ,_Y prevention_NN1 ,_Y and_CC treatment_NN1 programs_NN2 within_II correctional_JJ systems_NN2 represents_VVZ a_AT1 vital_JJ yet_RR under-utilized_VVN_JJ@_VVD strategy_NN1 to_TO reduce_VVI HCV_NP1 transmission_NN1 in_II society_NN1 as_II a_AT1 whole_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0    6 In the United States ( U.S. ) , estimates of hepatitis C virus ( HCV ) infection among the general population range between 2.7 million and 3.9 million , making Mast , 1994 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0    6 In_II the_AT United_NP1 States_NP1 (_Y U.S._NP1 )_Y ,_Y estimates_NN2_VVZ of_IO hepatitis_NN1 C_ZZ1_NP1 virus_NN1 (_Y HCV_NP1 )_Y infection_NN1 among_II the_AT general_JJ_NN1 population_NN1 range_NN1 between_II 2.7_MC million_M1 and_CC 3.9_MC million_M1 ,_Y making_VVG Mast_NN1 ,_Y 1994_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0    7 A number of studies have identified drug-related , sexual , and other drug-related risk factors associated with HCV infection .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0    7 A_AT1 number_NN1 of_IO studies_NN2 have_VH0 identified_VVN drug-related_NN1_JJ ,_Y sexual_JJ ,_Y and_CC other_JJ drug-related_JJ_NN1 risk_NN1 factors_NN2 associated_VVN with_IW HCV_NP1 infection_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0    8 Risk factors deemed to be associated with HCV infection include injection drug use , sexual contact with a steady partner infected with HCV , tattooing and ear piercing , intranasal cocaine use , multiple sexual partners , infants born to infected mothers , organ transplantation and occupational exposure to blood among health care workers ( Alter , 1997 ; Alter Mast , 1994 ; Centers for Disease Control , 2008 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0    8 Risk_VV0_NN1 factors_NN2 deemed_VVN to_TO be_VBI associated_VVN with_IW HCV_NP1 infection_NN1 include_VV0 injection_NN1 drug_NN1 use_NN1_VV0 ,_Y sexual_JJ contact_NN1 with_IW a_AT1 steady_JJ partner_NN1 infected_VVN_VVD with_IW HCV_NP1 ,_Y tattooing_VVG and_CC ear_NN1 piercing_NN1 ,_Y intranasal_JJ cocaine_NN1 use_NN1_VV0 ,_Y multiple_JJ sexual_JJ partners_NN2 ,_Y infants_NN2 born_VVN to_II infected_JJ mothers_NN2 ,_Y organ_NN1 transplantation_NN1 and_CC occupational_JJ exposure_NN1 to_II blood_NN1 among_II health_NN1 care_NN1 workers_NN2 (_Y Alter_VV0 ,_Y 1997_MC ;_Y Alter_VV0 Mast_NN1 ,_Y 1994_MC ;_Y Centers_NN2 for_IF Disease_NN1 Control_NN1 ,_Y 2008_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0    9 Furthermore , injection drug use is one of the strongest risk factors for HCV infection ( Centers for Disease Control , 2008 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0    9 Furthermore_RR ,_Y injection_NN1 drug_NN1 use_NN1 is_VBZ one_MC1 of_IO the_AT strongest_JJT risk_NN1 factors_NN2 for_IF HCV_NP1 infection_NN1 (_Y Centers_NN2 for_IF Disease_NN1 Control_NN1 ,_Y 2008_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   10 Not surprisingly , recent studies have identified heightened HCV seropositivity among incarcerated populations , presumably as risk behaviors associated with transmission are also associated with incarceration ( Macalino et al. , 2004 ; Macalino , Vlahov , Dickinson , Schwartzapfel , Rich , 2005 ; Solomon , Flynn , Muck , Vertefeuille , 2004 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   10 Not_XX surprisingly_RR ,_Y recent_JJ studies_NN2 have_VH0 identified_VVN heightened_JJ_VVD HCV_NP1 seropositivity_NN1 among_II incarcerated_JJ@ populations_NN2 ,_Y presumably_RR as_CSA risk_NN1 behaviors_NN2 associated_VVN with_IW transmission_NN1 are_VBR also_RR associated_VVN with_IW incarceration_NN1 (_Y Macalino_NP1 et_RA21 al._RA22 ,_Y 2004_MC ;_Y Macalino_NP1 ,_Y Vlahov_NP1 ,_Y Dickinson_NP1 ,_Y Schwartzapfel_NP1 ,_Y Rich_JJ_NP1@ ,_Y 2005_MC ;_Y Solomon_NP1 ,_Y Flynn_NP1 ,_Y Muck_NN1 ,_Y Vertefeuille_NP1 ,_Y 2004_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   11 Epidemiologic studies estimate HCV prevalence among inmates in the United al. , 2004 ; Macalino et al. , 2005 ; Reindollar , 1999 ; Solomon et al. , 2004 ; Vlahov , Nelson , Quinn , Kendig , 1993 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   11 Epidemiologic_JJ studies_NN2 estimate_VV0 HCV_NP1 prevalence_NN1 among_II inmates_NN2 in_II the_AT United_NP1 al._RA22 ,_Y 2004_MC ;_Y Macalino_NP1 et_RA21 al._RA22 ,_Y 2005_MC ;_Y Reindollar_NP1 ,_Y 1999_MC ;_Y Solomon_NP1 et_RA21 al._RA22 ,_Y 2004_MC ;_Y Vlahov_NP1 ,_Y Nelson_NP1 ,_Y Quinn_NP1 ,_Y Kendig_NP1_VV0_NN1 ,_Y 1993_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   12 Additionally , more than 7 million inmates of U.S. jails and correctional facilities are released annually ( Hammett , Harmon , Rhodes , 2002 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   12 Additionally_RR ,_Y more_DAR than_CSN 7_MC million_M1 inmates_NN2 of_IO U.S._NP1 jails_NN2 and_CC correctional_JJ facilities_NN2 are_VBR released_VVN annually_RR (_Y Hammett_NP1 ,_Y Harmon_NP1_NN1 ,_Y Rhodes_NP1 ,_Y 2002_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   13 When considered in light of the substantial numbers of inmates who are returned to society each year , many of whom are likely to be infected with HCV , the social and economic costs associated with the continued absence of systematic HCV screening , prevention , and treatment efforts in correctional settings is evident .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   13 When_CS considered_VVN in_II31 light_II32 of_II33 the_AT substantial_JJ numbers_NN2 of_IO inmates_NN2 who_PNQS are_VBR returned_VVN to_II society_NN1 each_DD1 year_NNT1 ,_Y many_DA2 of_IO whom_PNQO are_VBR likely_JJ to_TO be_VBI infected_VVN with_IW HCV_NP1 ,_Y the_AT social_JJ and_CC economic_JJ costs_NN2 associated_VVN with_IW the_AT continued_JJ absence_NN1 of_IO systematic_JJ HCV_NP1 screening_NN1_VVG ,_Y prevention_NN1 ,_Y and_CC treatment_NN1 efforts_NN2 in_II correctional_JJ settings_NN2 is_VBZ evident_JJ ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   14 While there is a growing base of research describing heightened HCV prevalence among incarcerated populations , few studies have examined associations between HCV infection and incarceration among drug using populations .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   14 While_CS there_EX is_VBZ a_AT1 growing_JJ base_NN1 of_IO research_NN1 describing_VVG heightened_JJ HCV_NP1 prevalence_NN1 among_II incarcerated_JJ@ populations_NN2 ,_Y few_DA2 studies_NN2 have_VH0 examined_VVN associations_NN2 between_II HCV_NP1 infection_NN1 and_CC incarceration_NN1 among_II drug_NN1 using_VVG populations_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   15 For example , extant research has not evaluated the extent to which differing levels of incarceration , such as short-term jail stays versus longer-term incarceration in correctional facilities and prisons , are associated with variations in HCV prevalence .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   15 For_REX21 example_REX22 ,_Y extant_JJ research_NN1 has_VHZ not_XX evaluated_VVN the_AT extent_NN1 to_II which_DDQ differing_JJ levels_NN2 of_IO incarceration_NN1 ,_Y such_II21 as_II22 short-term_JJ jail_NN1 stays_VVZ_NN2 versus_II longer-term_JJ incarceration_NN1 in_II correctional_JJ facilities_NN2 and_CC prisons_NN2 ,_Y are_VBR associated_VVN with_IW variations_NN2 in_II HCV_NP1 prevalence_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   16 Such information may help to improve efforts within correctional systems .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   16 Such_DA information_NN1 may_VM help_VVI to_TO improve_VVI efforts_NN2 within_II correctional_JJ systems_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   17 A related gap in the literature concerns racial/ethnic differences in HCV prevalence .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   17 A_AT1_ZZ1 related_JJ gap_NN1 in_II the_AT literature_NN1 concerns_VVZ racial/ethnic_JJ differences_NN2 in_II HCV_NP1 prevalence_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   18 General population studies have shown HCV prevalence among African Americans to be higher than that of whites ( Fleckenstein , 2004 ; Pyrsopoulos Jeffers , 2007 ; Rawls Vega , 2005 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   18 General_JJ_NN1 population_NN1 studies_NN2 have_VH0 shown_VVN HCV_NP1 prevalence_NN1 among_II African_JJ Americans_NN2 to_TO be_VBI higher_JJR than_CSN that_DD1 of_IO whites_NN2 (_Y Fleckenstein_NP1 ,_Y 2004_MC ;_Y Pyrsopoulos_NP2 Jeffers_NP1 ,_Y 2007_MC ;_Y Rawls_NP1 Vega_NP1 ,_Y 2005_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   19 However , three studies conducted with inmates in Texas ( Baillargeon et al. , 2003 ) , Maryland ( Solomon et al. , 2004 ) , and California ( Ruiz et al. , 1999 ) , each found HCV prevalence to be highest among whites .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   19 However_RR ,_Y three_MC studies_NN2 conducted_VVN_VVD with_IW inmates_NN2 in_II Texas_NP1 (_Y Baillargeon_NP1 et_RA21 al._RA22 ,_Y 2003_MC )_Y ,_Y Maryland_NP1 (_Y Solomon_NP1 et_RA21 al._RA22 ,_Y 2004_MC )_Y ,_Y and_CC California_NP1 (_Y Ruiz_NP1 et_RA21 al._RA22 ,_Y 1999_MC )_Y ,_Y each_DD1 found_VVD HCV_NP1 prevalence_NN1 to_TO be_VBI highest_JJT_RRT@ among_II whites_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   20 It is important to delineate whether and why racial differences in HCV exist for incarcerated populations in order to develop suitable prevention and treatment programs for vulnerable sub-populations .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   20 It_PPH1 is_VBZ important_JJ to_TO delineate_VVI whether_CSW and_CC why_RRQ racial_JJ differences_NN2 in_II HCV_NP1 exist_VV0 for_IF incarcerated_JJ@ populations_NN2 in_BCL21 order_BCL22 to_TO develop_VVI suitable_JJ prevention_NN1 and_CC treatment_NN1 programs_NN2 for_IF vulnerable_JJ sub-populations_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   21 Higher rates of disease among specific subgroups ( e.g. , racial ) may result in differences in risk behaviors ( e.g. , needle and works sharing ) in which they engage and need to be targeted .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   21 Higher_JJR rates_NN2 of_IO disease_NN1 among_II specific_JJ subgroups_NN2 (_Y e.g._REX ,_Y racial_JJ )_Y may_VM result_VVI in_II differences_NN2 in_II risk_NN1 behaviors_NN2 (_Y e.g._REX ,_Y needle_NN1 and_CC works_NN_VVZ sharing_VVG )_Y in_II which_DDQ they_PPHS2 engage_VV0 and_CC need_VV0_NN1 to_TO be_VBI targeted_VVN ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   22 This study initially examined associations between HCV prevalence , racial/ethnic status , and incarceration history among injection drug users .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   22 This_DD1 study_NN1 initially_RR examined_VVN_VVD_JJ@ associations_NN2 between_II HCV_NP1 prevalence_NN1 ,_Y racial/ethnic_JJ status_NN1 ,_Y and_CC incarceration_NN1 history_NN1 among_II injection_NN1 drug_NN1 users_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   23 Secondly , we sought to examine whether African American and white injection drug users .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   23 Secondly_RR ,_Y we_PPIS2 sought_VVD to_TO examine_VVI whether_CSW African_JJ American_JJ_NN1@ and_CC white_JJ injection_NN1 drug_NN1 users_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   24 METHODS The present study sample was collected as part of the U.S. site of the NEURO-HIV Epidemiologic Study , an epidemiological examination of neuropsychological , social , and behavioral risk factors of HIV , and hepatitis A , B , and C among injection and non-injection drug users with sites in the U.S. , South Africa , and Russia .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   24 METHODS_NN2 The_AT present_JJ_NN1 study_NN1 sample_NN1 was_VBDZ collected_VVN as_II part_NN1 of_IO the_AT U.S._NP1 site_NN1 of_IO the_AT NEURO-HIV_NP1 Epidemiologic_JJ Study_NN1 ,_Y an_AT1 epidemiological_JJ examination_NN1 of_IO neuropsychological_JJ ,_Y social_JJ ,_Y and_CC behavioral_JJ_NN1 risk_NN1 factors_NN2 of_IO HIV_NP1 ,_Y and_CC hepatitis_NN1 A_ZZ1 ,_Y B_ZZ1 ,_Y and_CC C_ZZ1_NP1 among_II injection_NN1 and_CC non-injection_JJ_NN1 drug_NN1 users_NN2 with_IW sites_NN2 in_II the_AT U.S._NP1 ,_Y South_NP1 Africa_NP1 ,_Y and_CC Russia_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   25 To be eligible for the study , participants had to report using injection or non-injection drugs during the previous 6 months , and be aged 15-50 years .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   25 To_TO be_VBI eligible_JJ for_IF the_AT study_NN1 ,_Y participants_NN2 had_VHD to_TO report_VVI using_VVG injection_NN1 or_CC non-injection_JJ_NN1 drugs_NN2 during_II the_AT previous_JJ 6_MC months_NNT2 ,_Y and_CC be_VBI aged_VVN 15-50_MCMC years_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   26 Non-injection drug users were not included in the present study , because HCV seroprevalence in this population was low .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   26 Non-injection_JJ_NN1 drug_NN1 users_NN2 were_VBDR not_XX included_VVN in_II the_AT present_JJ_NN1 study_NN1 ,_Y because_CS HCV_NP1 seroprevalence_NN1 in_II this_DD1 population_NN1 was_VBDZ low_JJ ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   27 Because we sought to examine associations between HCV seropositivity and incarceration status stratified by race/ethnicity , the present study sample was limited to African American and white participants and did not include subjects of Hispanic , Asian , Native American , or mixed race ethnicities ( n = 18 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   27 Because_CS we_PPIS2 sought_VVD to_TO examine_VVI associations_NN2 between_II HCV_NP1 seropositivity_NN1 and_CC incarceration_NN1 status_NN1 stratified_VVN by_II race/ethnicity_NN1 ,_Y the_AT present_JJ_NN1 study_NN1 sample_NN1 was_VBDZ limited_VVN to_II African_JJ American_JJ_NN1@ and_CC white_JJ participants_NN2 and_CC did_VDD not_XX include_VVI subjects_NN2 of_IO Hispanic_JJ ,_Y Asian_JJ_NN1@ ,_Y Native_JJ American_JJ_NN1@ ,_Y or_CC mixed_JJ@_VVD_VVN race_NN1 ethnicities_NN2 (_Y n_ZZ1 =_FO 18_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   28 The resulting study sample of 351 injection drug users was comprised of African American ( n = 136 ; 38.8% ) and white ( n = 212 ) of the sample being male .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   28 The_AT resulting_JJ study_NN1 sample_NN1 of_IO 351_MC injection_NN1 drug_NN1 users_NN2 was_VBDZ comprised_VVN of_IO African_JJ American_NN1@_JJ (_Y n_ZZ1 =_FO 136_MC ;_Y 38.8%_FO )_Y and_CC white_JJ_NN1@ (_Y n_ZZ1 =_FO 212_MC )_Y of_IO the_AT sample_NN1 being_VBG male_JJ_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   29 Further summarizes of sample characteristics are presented in Table 1 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   29 Further_RRR summarizes_VVZ of_IO sample_NN1 characteristics_NN2 are_VBR presented_VVN in_II Table_NN1 1_MC1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   30 Full approval of the study protocol by the Johns Hopkins Bloomberg School of Public Health Institutional Review Board in 2001 has since received annual reviews and approval .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   30 Full_JJ approval_NN1 of_IO the_AT study_NN1 protocol_NN1 by_II the_AT Johns_NP1 Hopkins_NP1 Bloomberg_NP1 School_NN1 of_IO Public_JJ_NN1 Health_NN1 Institutional_JJ Review_NN1 Board_NN1 in_II 2001_MC has_VHZ since_RR@ received_VVN annual_JJ reviews_NN2 and_CC approval_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   31 Expert clinicians who underwent extensive training , including formal course work in HIV epidemiology and prevention , seminars on psycho-diagnostic and neuropsychological assessment , and weekly team meetings and supervision , conducted all participant interviews and counseling sessions .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   31 Expert_NN1_JJ@ clinicians_NN2 who_PNQS underwent_VVD extensive_JJ training_NN1 ,_Y including_II_VVG@ formal_JJ course_NN1 work_NN1_VV0 in_II HIV_NP1 epidemiology_NN1 and_CC prevention_NN1 ,_Y seminars_NN2 on_II psycho-diagnostic_JJ and_CC neuropsychological_JJ assessment_NN1 ,_Y and_CC weekly_JJ team_NN1 meetings_NN2 and_CC supervision_NN1 ,_Y conducted_VVD_VVN all_DB participant_NN1 interviews_NN2 and_CC counseling_NN1 sessions_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   32 PARTICIPANT SAMPLE SELECTION Enrollment included multiple recruitment strategies , such as street outreach , advertisements in local newspapers , outreach at local needle exchange sites , as well as referrals from enrolled participants , and social service agencies .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   32 PARTICIPANT_NN1 SAMPLE_NN1 SELECTION_NN1 Enrollment_NN1_NP1 included_VVD_VVN multiple_JJ recruitment_NN1 strategies_NN2 ,_Y such_II21 as_II22 street_NN1 outreach_NN1_VV0 ,_Y advertisements_NN2 in_II local_JJ newspapers_NN2 ,_Y outreach_VV0_NN1 at_II local_JJ needle_NN1 exchange_NN1 sites_NN2 ,_Y as_II31 well_II32 as_II33 referrals_NN2 from_II enrolled_JJ@ participants_NN2 ,_Y and_CC social_JJ service_NN1 agencies_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   33 Informed consent obtained at the outset of the baseline assessment also addressed permission for follow-up contacts .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   33 Informed_JJ@_VVN consent_NN1 obtained_VVN_VVD at_II the_AT outset_NN1 of_IO the_AT baseline_NN1 assessment_NN1 also_RR addressed_VVN_JJ@_VVD permission_NN1 for_IF follow-up_JJ_NN1 contacts_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   34 Participant incentives included $45 for the baseline assessment , $10 for locator visits , and $55 for follow-up assessments .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   34 Participant_NN1 incentives_NN2 included_VVD_VVN $45_NNU for_IF the_AT baseline_NN1 assessment_NN1 ,_Y $10_NNU for_IF locator_NN1 visits_NN2 ,_Y and_CC $55_NNU for_IF follow-up_JJ_NN1 assessments_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   35 DATA COLLECTION The baseline assessment was comprised of a standardized face-to-face HIV-Risk Behavior Interview , a battery of neuropsychological tests focusing mainly on executive functions , attention and urine sample collection .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   35 DATA_NN COLLECTION_NN1 The_AT baseline_NN1 assessment_NN1 was_VBDZ comprised_VVN of_IO a_AT1 standardized_JJ face-to-face_JJ HIV-Risk_JJ_NN1 Behavior_NN1_NP1 Interview_NN1 ,_Y a_AT1 battery_NN1 of_IO neuropsychological_JJ tests_NN2 focusing_VVG mainly_RR on_II executive_NN1_JJ@ functions_NN2 ,_Y attention_NN1 and_CC urine_NN1 sample_NN1 collection_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   36 Tests of HIV , hepatitis A , hepatitis B , and hepatitis C used blood samples drawn by expert phlebotomists .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   36 Tests_NN2 of_IO HIV_NP1 ,_Y hepatitis_NN1 A_ZZ1 ,_Y hepatitis_NN1 B_ZZ1 ,_Y and_CC hepatitis_NN1 C_ZZ1 used_JJ blood_NN1 samples_NN2 drawn_VVN by_II expert_NN1_JJ@ phlebotomists_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   37 Urinalysis tested for recent use of cannabinoids , opiates , cocaine , amphetamine , methamphetamine , methadone , PCP , barbiturates , benzodiazepines , tricyclic antidepressants , MDMA , and oxycodone .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   37 Urinalysis_NP1@_NN1 tested_VVD for_IF recent_JJ use_NN1 of_IO cannabinoids_NN2 ,_Y opiates_NN2_VVZ ,_Y cocaine_NN1 ,_Y amphetamine_VV0_NN1 ,_Y methamphetamine_VV0_NN1 ,_Y methadone_VV0_NN1 ,_Y PCP_NP1 ,_Y barbiturates_NN2 ,_Y benzodiazepines_NN2_VVZ ,_Y tricyclic_JJ antidepressants_NN2 ,_Y MDMA_NP1_NN1 ,_Y and_CC oxycodone_NN1_VV0 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   38 Risk-reduction counseling provided to participants was pertinent to HIV/AIDS , viral hepatitis , and other STDs as well as referral information to community-based drug treatment and social services .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   38 Risk-reduction_JJ_NN1 counseling_NN1 provided_VVN_VVD to_II participants_NN2 was_VBDZ pertinent_JJ to_II HIV/AIDS_FU ,_Y viral_JJ hepatitis_NN1 ,_Y and_CC other_JJ STDs_NN2 as_II31 well_II32 as_II33 referral_NN1 information_NN1 to_II community-based_JJ_NN1 drug_NN1 treatment_NN1 and_CC social_JJ services_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   39 MEASURES The HIV-Risk Behavior Interview was originally adapted from a similar interview used for the REACH study .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   39 MEASURES_NN2_VVZ@ The_AT HIV-Risk_JJ_NN1 Behavior_NN1 Interview_NN1 was_VBDZ originally_RR adapted_VVN_VVD from_II a_AT1 similar_JJ interview_NN1 used_VVN_VVD for_IF the_AT REACH_NN1 study_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   40 The interview consisted of questions on demographics and medical , educational , and neurodevelopment histories , including STDs and detailed behavioral information about drug use , sexual practices , social networks , and community violence ( Strathdee Sherman , 2003 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   40 The_AT interview_NN1 consisted_VVN_VVD of_IO questions_NN2 on_II demographics_NN2_NN1 and_CC medical_JJ ,_Y educational_JJ ,_Y and_CC neurodevelopment_NN1 histories_NN2 ,_Y including_II_VVG@ STDs_NN2 and_CC detailed_JJ behavioral_JJ_NN1 information_NN1 about_II drug_NN1 use_NN1_VV0 ,_Y sexual_JJ practices_NN2 ,_Y social_JJ networks_NN2 ,_Y and_CC community_NN1 violence_NN1 (_Y Strathdee_NP1 Sherman_NP1 ,_Y 2003_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   41 Demographic variables collected via self-report included gender , age , education , and race .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   41 Demographic_JJ variables_NN2 collected_VVN_VVD via_II self-report_NN1_JJ included_VVD_VVN_JJ% gender_NN1 ,_Y age_NN1_VV0@ ,_Y education_NN1 ,_Y and_CC race_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   42 Participants self-reported their race/ethnicity and were categorized as African American ; Asian or Pacific Islander ; Hispanic or Latino ; Native American ; White ; or multiple racial had some high school , a general equivalency degree ( GED ) , a high school diploma , or some college experience , with participants having no high school education as the referent group .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   42 Participants_NN2 self-reported_NN1_JJ their_APPGE race/ethnicity_NN1 and_CC were_VBDR categorized_VVN@ as_CSA_RG@_II@ African_JJ American_JJ_NN1@ ;_Y Asian_JJ or_CC Pacific_NP1 Islander_NP1_NN1 ;_Y Hispanic_JJ or_CC Latino_NP1_NN1 ;_Y Native_JJ American_JJ_NN1@ ;_Y White_NP1_JJ ;_Y or_CC multiple_JJ racial_JJ had_VHD some_DD high_JJ school_NN1 ,_Y a_AT1 general_JJ_NN1 equivalency_NN1 degree_NN1 (_Y GED_NP1 )_Y ,_Y a_AT1 high_JJ school_NN1 diploma_NN1 ,_Y or_CC some_DD college_NN1 experience_NN1 ,_Y with_IW participants_NN2 having_VHG no_AT high_JJ school_NN1 education_NN1 as_II_CSA the_AT referent_JJ_NN1 group_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   43 The interview obtained data on lifetime incarceration status , distinguishing between jail incarceration and incarceration in correctional facilities or prisons .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   43 The_AT interview_NN1 obtained_VVD_VVN data_NN on_II lifetime_NNT1 incarceration_NN1 status_NN1 ,_Y distinguishing_VVG between_II jail_NN1 incarceration_NN1 and_CC incarceration_NN1 in_II correctional_JJ facilities_NN2 or_CC prisons_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   44 Typically , the length of a jail stay in Maryland during the study period was between one and 30 days , while the length of stay in a correctional facility or prison was typically for a period of months or longer .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   44 Typically_RR ,_Y the_AT length_NN1 of_IO a_AT1 jail_NN1 stay_VV0_NN1@ in_II Maryland_NP1 during_II the_AT study_NN1 period_NN1 was_VBDZ between_II one_MC1 and_CC 30_MC days_NNT2 ,_Y while_CS the_AT length_NN1 of_IO stay_NN1@_VV0 in_II a_AT1 correctional_JJ facility_NN1 or_CC prison_NN1 was_VBDZ typically_RR for_IF a_AT1 period_NN1 of_IO months_NNT2 or_CC longer_RRR_JJR ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   45 Further variables of interest included duration of injection drug use , which was also collected via self-report .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   45 Further_JJR variables_NN2 of_IO interest_NN1 included_VVD_VVN duration_NN1 of_IO injection_NN1 drug_NN1 use_NN1_VV0 ,_Y which_DDQ was_VBDZ also_RR collected_VVN_VVD via_II self-report_NN1_JJ ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   46 Participants were grouped into 3 categories of injection drug use duration : less than 1 year of use , 1-5 years and greater than 5 years of injection drug use ( Galeazzi , Tufano , Barbierato , Bortolotti , 1995 ; Garfein , Vlahov , Galai , Doherty , Nelson , 1996 ; Hagan et al. , 2007 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   46 Participants_NN2 were_VBDR grouped_VVN into_II 3_MC categories_NN2 of_IO injection_NN1 drug_NN1 use_NN1_VV0 duration_NN1 :_Y less_DAR_RRR than_CSN 1_MC1 year_NNT1 of_IO use_NN1 ,_Y 1-5_MCMC years_NNT2 and_CC greater_JJR than_CSN 5_MC years_NNT2 of_IO injection_NN1 drug_NN1 use_NN1 (_Y Galeazzi_NP1_NN1 ,_Y Tufano_NP1_NN1 ,_Y Barbierato_NP1_NN1 ,_Y Bortolotti_NP1_NN1 ,_Y 1995_MC ;_Y Garfein_NP1 ,_Y Vlahov_NP1 ,_Y Galai_NP1_NN1 ,_Y Doherty_NP1_NN1 ,_Y Nelson_NP1 ,_Y 1996_MC ;_Y Hagan_NP1 et_RA21 al._RA22 ,_Y 2007_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   47 HCV ANTIBODY TESTING Tests of blood specimens used Ortho-Clinical Diagnostics Inc .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   47 HCV_NP1 ANTIBODY_NP1_NN1 TESTING_NN1_VVG_NP1@ Tests_NN2 of_IO blood_NN1 specimens_NN2 used_VVD_VVN_JJ Ortho-Clinical_JJ Diagnostics_NN1 Inc_JJ ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   48 HCV for the detection of antibodies to hepatitis C Virus ( Anti-HCV ) in human serum and plasma samples .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   48 HCV_NP1 for_IF the_AT detection_NN1 of_IO antibodies_NN2 to_II hepatitis_NN1 C_ZZ1_NP1 Virus_NN1 (_Y Anti-HCV_JJ )_Y in_II human_JJ_NN1 serum_NN1 and_CC plasma_NN1 samples_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   49 The Ortho HCV V 3.0 ELISA Test System used recombinant antigens provided by Chiron Corporation .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   49 The_AT Ortho_NP1_NN1 HCV_NP1 V_ZZ1_II@ 3.0_MC ELISA_NP1 Test_NN1_VV0 System_NN1 used_VVD_JJ_VVN recombinant_JJ_NN1 antigens_NN2 provided_VVN by_II Chiron_NP1_NN1 Corporation_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   50 STATISTICAL METHODS Statistical analysis included the sample of 351 injection drug users who reported African American or white racial/ethnic status .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   50 STATISTICAL_JJ METHODS_NN2 Statistical_JJ analysis_NN1 included_VVD_VVN the_AT sample_NN1 of_IO 351_MC injection_NN1 drug_NN1 users_NN2 who_PNQS reported_VVD African_JJ American_JJ_NN1@ or_CC white_JJ racial/ethnic_JJ status_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   51 Initially , the association between HCV seropositivity , sociodemographic , injection drug duration and incarceration status variables was evaluated using the total sample .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   51 Initially_RR ,_Y the_AT association_NN1 between_II HCV_NP1 seropositivity_NN1 ,_Y sociodemographic_JJ ,_Y injection_NN1 drug_NN1 duration_NN1 and_CC incarceration_NN1 status_NN1 variables_NN2 was_VBDZ evaluated_VVN using_VVG the_AT total_JJ_NN1 sample_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   52 Use of descriptive statistics identified proportions of the sample that tested positive for HCV across the levels of each sociodemographic and incarceration status variable .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   52 Use_NN1_VV0 of_IO descriptive_JJ statistics_NN identified_VVN_VVD@_JJ% proportions_NN2 of_IO the_AT sample_NN1 that_CST tested_VVD positive_JJ for_IF HCV_NP1 across_II the_AT levels_NN2 of_IO each_DD1 sociodemographic_JJ and_CC incarceration_NN1 status_NN1 variable_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   53 Analyses of associations included comparisons of participants reporting a lifetime history of jail incarceration only , participants reporting a history of correctional facility/prison incarceration and participants reporting no history of incarceration using simple logistic regressions to compute unadjusted odds ratios .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   53 Analyses_NN2 of_IO associations_NN2 included_VVD_VVN comparisons_NN2 of_IO participants_NN2 reporting_VVG a_AT1 lifetime_NNT1 history_NN1 of_IO jail_NN1 incarceration_NN1 only_RR ,_Y participants_NN2 reporting_VVG a_AT1 history_NN1 of_IO correctional_JJ facility/prison_NN1 incarceration_NN1 and_CC participants_NN2 reporting_VVG no_AT history_NN1 of_IO incarceration_NN1 using_VVG simple_JJ logistic_JJ regressions_NN2 to_TO compute_VVI unadjusted_JJ odds_NN2 ratios_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   54 Multiple logistic regression models were subsequently fit to assess associations between HCV seropositivity , race/ethnic status , and incarceration status with adjustment for gender , age , education and duration of injection drug use .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   54 Multiple_JJ logistic_JJ regression_NN1 models_NN2 were_VBDR subsequently_RR fit_VV0_JJ to_TO assess_VVI associations_NN2 between_II HCV_NP1 seropositivity_NN1 ,_Y race/ethnic_FU status_NN1 ,_Y and_CC incarceration_NN1 status_NN1 with_IW adjustment_NN1 for_IF gender_NN1 ,_Y age_NN1_VV0@ ,_Y education_NN1 and_CC duration_NN1 of_IO injection_NN1 drug_NN1 use_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   55 Further , a race/ethnicity stratified analysis examined simple and multiple and white participants , separately .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   55 Further_RRR_JJR ,_Y a_AT1 race/ethnicity_NN1 stratified_JJ_VVN analysis_NN1 examined_VVD_VVN simple_JJ and_CC multiple_JJ_NN1 and_CC white_JJ participants_NN2 ,_Y separately_RR ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   56 All statistical analyses were computed using SAS version 9.1 ( SAS 9.1 2002-2003 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   56 All_DB_RR@ statistical_JJ analyses_NN2 were_VBDR computed_VVN using_VVG SAS_NP1 version_NN1 9.1_MC (_Y SAS_NP1 9.1_MC 2002-2003_MCMC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   57 RESULTS Sixty-nine percent of the sample was positive for HCV ( n = 243 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   57 RESULTS_NN2 Sixty-nine_MC percent_NNU of_IO the_AT sample_NN1 was_VBDZ positive_JJ for_IF HCV_NP1 (_Y n_ZZ1 =_FO 243_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   58 Eighteen percent ( n = 64 ) of participants reported no lifetime history of any incarceration , 49% ( n = 172 ) reported jail incarceration in their lifetime , and 33% ( n = 115 ) reported correctional facility incarceration in their lifetime .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   58 Eighteen_MC percent_NNU (_Y n_ZZ1 =_FO 64_MC )_Y of_IO participants_NN2 reported_VVD_VVN no_AT lifetime_NNT1 history_NN1 of_IO any_DD incarceration_NN1 ,_Y 49%_NNU (_Y n_ZZ1 =_FO 172_MC )_Y reported_VVD_JJ@ jail_NN1 incarceration_NN1 in_II their_APPGE lifetime_NNT1 ,_Y and_CC 33%_NNU (_Y n_ZZ1 =_FO 115_MC )_Y reported_VVD correctional_JJ facility_NN1 incarceration_NN1 in_II their_APPGE lifetime_NNT1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   59 Among the 115 participants reporting correctional facility incarceration in their lifetime , 92% ( n = 106 ) also reported a history of jail incarceration .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   59 Among_II the_AT 115_MC participants_NN2 reporting_VVG correctional_JJ facility_NN1 incarceration_NN1 in_II their_APPGE lifetime_NNT1 ,_Y 92%_NNU (_Y n_ZZ1 =_FO 106_MC )_Y also_RR reported_VVN_VVD a_AT1 history_NN1 of_IO jail_NN1 incarceration_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   60 All participants reported injection drug use , with 55% ( n = 192 ) of the sample reporting greater-than 5 years of use .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   60 All_DB participants_NN2 reported_VVD_VVN injection_NN1 drug_NN1 use_NN1_VV0 ,_Y with_IW 55%_NNU (_Y n_ZZ1 =_FO 192_MC )_Y of_IO the_AT sample_NN1 reporting_NN1 greater-than_CSN 5_MC years_NNT2 of_IO use_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   61 Seventy-six percent of participants reported that heroin by itself was their drug of choice , while 9% reported speedball , and 6% reported cocaine by itself as their drug of choice .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   61 Seventy-six_MC percent_NNU of_IO participants_NN2 reported_VVD_VVN that_DD1_CST heroin_NN1 by_II itself_PPX1 was_VBDZ their_APPGE drug_NN1 of_IO choice_NN1 ,_Y while_CS 9%_NNU reported_JJ@_VVN_VVD speedball_NN1 ,_Y and_CC 6%_NNU reported_JJ@_VVN_VVD cocaine_NN1 by_II itself_PPX1 as_CSA_II@ their_APPGE drug_NN1 of_IO choice_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   62 Ninety-seven percent of participants reported injecting heroin in their lifetime , and 78% reported injecting heroin in the past 6 months .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   62 Ninety-seven_MC percent_NNU of_IO participants_NN2 reported_VVD_VVN injecting_VVG heroin_NN1 in_II their_APPGE lifetime_NNT1 ,_Y and_CC 78%_NNU reported_VVD_VVN injecting_VVG heroin_NN1 in_II the_AT past_JJ 6_MC months_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   63 Seventy-three percent of participants reported in the past 6 months .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   63 Seventy-three_MC percent_NNU of_IO participants_NN2 reported_VVD_VVN in_II the_AT past_JJ 6_MC months_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   64 Seventy-three percent of participants reported injecting cocaine in their lifetime , while 49% reported injecting cocaine in the past 6 months .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   64 Seventy-three_MC percent_NNU of_IO participants_NN2 reported_VVD_VVN injecting_VVG cocaine_NN1 in_II their_APPGE lifetime_NNT1 ,_Y while_CS 49%_NNU reported_VVD_VVN injecting_VVG cocaine_NN1 in_II the_AT past_JJ 6_MC months_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   65 Approximately one-quarter ( n = 90 ; 26% ) of participants reported graduating from high school , with most ( 40% ) participants reporting having some high school education .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   65 Approximately_RR one-quarter_MF (_Y n_ZZ1 =_FO 90_MC ;_Y 26%_NNU )_Y of_IO participants_NN2 reported_VVD_VVN graduating_VVG from_II high_JJ school_NN1 ,_Y with_IW most_DAT_RGT (_Y 40%_NNU )_Y participants_NN2 reporting_NN1_VVG having_VHG some_DD high_JJ school_NN1 education_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   66 Table 1 summarizes the distributions of incarceration and demographic variables and their associations with HCV prevalence .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   66 Table_NN1_VV0% 1_MC1 summarizes_VVZ the_AT distributions_NN2 of_IO incarceration_NN1 and_CC demographic_JJ variables_NN2 and_CC their_APPGE associations_NN2 with_IW HCV_NP1 prevalence_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   67 The unadjusted results indicate that when compared with drug users having no high school education , graduating from high school odds ratio ( OR ) = 0.3 , 95% CI = 0.1 , 0.9 and having some college experience ( OR = 0.2 , 95% CI = 0.1-0.6 ) produced a protective effect against HCV infection .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   67 The_AT unadjusted_JJ results_NN2 indicate_VV0 that_CST when_CS compared_VVN with_IW drug_NN1 users_NN2 having_VHG no_AT high_JJ school_NN1 education_NN1 ,_Y graduating_VVG from_II high_JJ school_NN1 odds_NN2 ratio_NN1 (_Y OR_CC )_Y =_FO 0.3_MC ,_Y 95%_NNU CI_FO =_FO 0.1_MC ,_Y 0.9_MC and_CC having_VHG some_DD college_NN1 experience_NN1 (_Y OR_CC =_FO 0.2_MC ,_Y 95%_NNU CI_FO =_FO 0.1-0.6_MCMC )_Y produced_VVD a_AT1 protective_JJ effect_NN1 against_II HCV_NP1 infection_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   68 Without adjustment , the prevalence of HCV was significantly greater among injection drug users with a history of correctional facility incarceration ( 83% ) ( OR = 2.9 , 95% CI = 1.5-5.9 ) , when compared to drug users with no lifetime incarceration ( 61% ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   68 Without_IW adjustment_NN1 ,_Y the_AT prevalence_NN1 of_IO HCV_NP1 was_VBDZ significantly_RR greater_JJR among_II injection_NN1 drug_NN1 users_NN2 with_IW a_AT1 history_NN1 of_IO correctional_JJ facility_NN1 incarceration_NN1 (_Y 83%_NNU )_Y (_Y OR_CC =_FO 2.9_MC ,_Y 95%_NNU CI_FO =_FO 1.5-5.9_MCMC )_Y ,_Y when_CS_RRQ compared_VVN to_II drug_NN1 users_NN2 with_IW no_AT lifetime_NNT1 incarceration_NN1 (_Y 61%_NNU )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   69 Also without adjustment , duration of injection drug use was highly years of injection drug use were twice as likely to test positive for HCV ( OR = 2.2 , 95% CI = 1.2 , 4.3 ) , compared to participants reporting less than 1 year of injection drug use .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   69 Also_RR without_IW adjustment_NN1 ,_Y duration_NN1 of_IO injection_NN1 drug_NN1 use_NN1 was_VBDZ highly_RR years_NNT2 of_IO injection_NN1 drug_NN1 use_NN1 were_VBDR twice_RR as_RG likely_JJ to_TO test_VVI positive_JJ for_IF HCV_NP1 (_Y OR_CC =_FO 2.2_MC ,_Y 95%_NNU CI_FO =_FO 1.2_MC ,_Y 4.3_MC )_Y ,_Y compared_VVN to_II participants_NN2 reporting_VVG less_DAR_RRR than_CSN 1_MC1 year_NNT1 of_IO injection_NN1 drug_NN1 use_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   70 The odds of HCV were greater for participants reporting greater than 5 years of injection drug use ( OR = 7.6 , 95% CI = 4.1 , 14.3 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   70 The_AT odds_NN2 of_IO HCV_NP1 were_VBDR greater_JJR for_IF participants_NN2 reporting_VVG greater_JJR than_CSN 5_MC years_NNT2 of_IO injection_NN1 drug_NN1 use_NN1 (_Y OR_CC =_FO 7.6_MC ,_Y 95%_NNU CI_FO =_FO 4.1_MC ,_Y 14.3_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   71 Adjusting for gender , age , education , lifetime incarceration status and injection drug duration , whites were twice as likely to test positive for HCV when compared to African Americans ( adjusted odds ratio AOR = 2.0 , 95% CI = 1.0-3.9 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   71 Adjusting_VVG for_IF gender_NN1 ,_Y age_NN1_VV0@ ,_Y education_NN1 ,_Y lifetime_NNT1 incarceration_NN1 status_NN1 and_CC injection_NN1 drug_NN1 duration_NN1 ,_Y whites_NN2 were_VBDR twice_RR as_RG likely_JJ to_TO test_VVI positive_JJ for_IF HCV_NP1 when_CS_RRQ compared_VVN to_II African_JJ Americans_NN2 (_Y adjusted_JJ@_VVN odds_NN2 ratio_NN1 AOR_NN1_NP1 =_FO 2.0_MC ,_Y 95%_NNU CI_FO =_FO 1.0-3.9_MCMC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   72 The significance of the association between a correctional facility stay and HCV infection was maintained with adjustment ( AOR = 2.6 , 95% CI = 1.2 , 6.1 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   72 The_AT significance_NN1 of_IO the_AT association_NN1 between_II a_AT1 correctional_JJ facility_NN1 stay_NN1@_VV0 and_CC HCV_NP1 infection_NN1 was_VBDZ maintained_VVN with_IW adjustment_NN1 (_Y AOR_NP1_NN1 =_FO 2.6_MC ,_Y 95%_NNU CI_FO =_FO 1.2_MC ,_Y 6.1_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   73 Additionally , when compared against drug users having no high school education , having some college experience ( AOR = 0.3 , 95% CI = 0.1-1.0 ) produced an independent protective effect against HCV infection .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   73 Additionally_RR ,_Y when_CS_RRQ compared_VVN against_II drug_NN1 users_NN2 having_VHG no_AT high_JJ school_NN1 education_NN1 ,_Y having_VHG some_DD college_NN1 experience_NN1 (_Y AOR_NP1_NN1 =_FO 0.3_MC ,_Y 95%_NNU CI_FO =_FO 0.1-1.0_MCMC )_Y produced_VVD an_AT1 independent_JJ protective_JJ effect_NN1 against_II HCV_NP1 infection_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   74 ANALYSIS STRATIFIED BY RACE/ETHNICITY Only duration of injection drug use other covariates in the multiple logistic regression model .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   74 ANALYSIS_NN1 STRATIFIED_VVN BY_II RACE/ETHNICITY_NN1 Only_JJ duration_NN1 of_IO injection_NN1 drug_NN1 use_NN1 other_JJ covariates_NN2 in_II the_AT multiple_JJ_NN1 logistic_JJ regression_NN1 model_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   75 Compared to African American participants who reported less than 1 year of drug use , participants who reported greater than 5 years of injection drug use were about 13 times more likely to test positive for HCV , ( AOR = 13.3 ; 95% CI = 4.5 , 39.5 ) , adjusting for gender , age , education , and lifetime incarceration .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   75 Compared_VVN to_II African_JJ American_JJ participants_NN2 who_PNQS reported_VVD less_DAR_RRR than_CSN 1_MC1 year_NNT1 of_IO drug_NN1 use_NN1_VV0 ,_Y participants_NN2 who_PNQS reported_VVD greater_JJR than_CSN 5_MC years_NNT2 of_IO injection_NN1 drug_NN1 use_NN1 were_VBDR about_RG 13_MC times_NNT2 more_RRR_RGR likely_JJ to_TO test_VVI positive_JJ for_IF HCV_NP1 ,_Y (_Y AOR_NP1_NN1 =_FO 13.3_MC ;_Y 95%_NNU CI_FO =_FO 4.5_MC ,_Y 39.5_MC )_Y ,_Y adjusting_VVG for_IF gender_NN1 ,_Y age_NN1_VV0@ ,_Y education_NN1 ,_Y and_CC lifetime_NNT1 incarceration_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   76 Though not identical , the pattern of results among white participants was similar to that of the entire sample ( Table 2 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   76 Though_CS not_XX identical_JJ ,_Y the_AT pattern_NN1 of_IO results_NN2 among_II white_JJ participants_NN2 was_VBDZ similar_JJ to_II that_DD1 of_IO the_AT entire_JJ sample_NN1 (_Y Table_NN1 2_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   77 Namely , when compared against whites having no high school education , whites having some college exhibited significantly lower HCV infection prevalence .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   77 Namely_REX ,_Y when_CS_RRQ compared_VVN against_II whites_NN2 having_VHG no_AT high_JJ school_NN1 education_NN1 ,_Y whites_NN2 having_VHG some_DD college_NN1 exhibited_VVN significantly_RR lower_JJR_RRR@ HCV_NP1 infection_NN1 prevalence_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   78 Correctional facility stay and longer duration of injection drug use in both the unadjusted and adjusted models were associated with higher HCV prevalence .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   78 Correctional_JJ facility_NN1 stay_NN1@_VV0 and_CC longer_JJR duration_NN1 of_IO injection_NN1 drug_NN1 use_NN1_VV0 in_II both_DB2 the_AT unadjusted_JJ and_CC adjusted_JJ@_VVN models_NN2 were_VBDR associated_VVN with_IW higher_JJR HCV_NP1 prevalence_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   79 In adjusted models , injectors with a history of correction facility stay were nearly 15 times more likely to test positive for HCV when compared to injectors with no history of incarceration ( AOR = 14.7 , 95% CI = 2.9 , 79.5 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   79 In_II adjusted_JJ@ models_NN2 ,_Y injectors_NN2 with_IW a_AT1 history_NN1 of_IO correction_NN1 facility_NN1 stay_NN1@ were_VBDR nearly_RR 15_MC times_NNT2 more_RRR_RGR likely_JJ to_TO test_VVI positive_JJ for_IF HCV_NP1 when_CS_RRQ compared_VVN to_II injectors_NN2 with_IW no_AT history_NN1 of_IO incarceration_NN1 (_Y AOR_NP1_NN1 =_FO 14.7_MC ,_Y 95%_NNU CI_FO =_FO 2.9_MC ,_Y 79.5_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   80 Drug users with to test positive for HCV when compared to drug users with less-than one year of injection drug use ( AOR = 4.6 , 95% CI = 1.8 , 12.0 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   80 Drug_NN1 users_NN2 with_IW to_TO test_VVI positive_JJ for_IF HCV_NP1 when_CS_RRQ compared_VVN to_II drug_NN1 users_NN2 with_IW less-than_CSN one_MC1 year_NNT1 of_IO injection_NN1 drug_NN1 use_NN1 (_Y AOR_NP1_NN1 =_FO 4.6_MC ,_Y 95%_NNU CI_FO =_FO 1.8_MC ,_Y 12.0_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   81 DISCUSSION Our study findings are consistent with a large base of research documenting high rates of HCV among incarcerated populations ( Macalino et al. , 2005 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   81 DISCUSSION_NN1 Our_APPGE study_NN1 findings_NN2 are_VBR consistent_JJ with_IW a_AT1 large_JJ base_NN1 of_IO research_NN1 documenting_VVG high_JJ rates_NN2 of_IO HCV_NP1 among_II incarcerated_JJ@ populations_NN2 (_Y Macalino_NP1 et_RA21 al._RA22 ,_Y 2005_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   82 The overall rates of HCV prevalence associated with various levels of incarceration found in our study are higher than rates of HCV found in extant studies of general populations of incarcerated adults .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   82 The_AT overall_JJ_NN1 rates_NN2 of_IO HCV_NP1 prevalence_NN1 associated_VVN with_IW various_JJ levels_NN2 of_IO incarceration_NN1 found_VVN_VVD in_II_RP@ our_APPGE study_NN1 are_VBR higher_JJR than_CSN rates_NN2 of_IO HCV_NP1 found_VVD in_II_RP@ extant_JJ studies_NN2 of_IO general_JJ_NN1 populations_NN2 of_IO incarcerated_JJ@ adults_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   83 In these studies , rates of HCV prevalence ranged from 16% to 41% ( Macalino et al. , 2005 ; Macalino et al. , 2004 ; Reindollar , 1999 ; Solomon et al. , 2004 ; Vlahov et al. , 1993 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   83 In_II these_DD2 studies_NN2 ,_Y rates_NN2 of_IO HCV_NP1 prevalence_NN1 ranged_VVN_VVD from_II 16%_NNU to_II 41%_NNU (_Y Macalino_NP1 et_RA21 al._RA22 ,_Y 2005_MC ;_Y Macalino_NP1 et_RA21 al._RA22 ,_Y 2004_MC ;_Y Reindollar_NP1 ,_Y 1999_MC ;_Y Solomon_NP1 et_RA21 al._RA22 ,_Y 2004_MC ;_Y Vlahov_NP1 et_RA21 al._RA22 ,_Y 1993_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   84 Consistent with previous research with drug using and incarcerated populations , whites in our study were significantly more likely than African Americans to test positive for hepatitis C ( Baillargeon et al. , 2003 ; Ruiz et al. , 1999 ; Solomon et al. , 2004 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   84 Consistent_JJ with_IW previous_JJ research_NN1 with_IW drug_NN1 using_VVG and_CC incarcerated_VVD_JJ@ populations_NN2 ,_Y whites_NN2_VVZ@ in_II our_APPGE study_NN1 were_VBDR significantly_RR more_RGR likely_JJ than_CSN African_JJ Americans_NN2 to_TO test_VVI positive_JJ for_IF hepatitis_NN1 C_ZZ1_NP1 (_Y Baillargeon_NP1 et_RA21 al._RA22 ,_Y 2003_MC ;_Y Ruiz_NP1 et_RA21 al._RA22 ,_Y 1999_MC ;_Y Solomon_NP1 et_RA21 al._RA22 ,_Y 2004_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   85 Past studies either did not control for injection et al. , 1999 ) , or included both non-injectors and injectors ( Ruiz et al. , 1999 ; Solomon et al. , 2004 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   85 Past_JJ_II_NN1 studies_NN2 either_RR_DD1 did_VDD not_XX control_VVI for_IF injection_NN1 et_RA21 al._RA22 ,_Y 1999_MC )_Y ,_Y or_CC included_VVD_VVN both_RR non-injectors_NN2 and_CC injectors_NN2 (_Y Ruiz_NP1 et_RA21 al._RA22 ,_Y 1999_MC ;_Y Solomon_NP1 et_RA21 al._RA22 ,_Y 2004_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   86 In our sample of injection drug users , when controlling for potentially influential covariates such as duration of injection drug use , the odds of HCV infection for whites compared to African Americans increased .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   86 In_II our_APPGE sample_NN1 of_IO injection_NN1 drug_NN1 users_NN2 ,_Y when_CS controlling_VVG for_IF potentially_RR influential_JJ covariates_NN2 such_II21 as_II22 duration_NN1 of_IO injection_NN1 drug_NN1 use_NN1_VV0 ,_Y the_AT odds_NN2 of_IO HCV_NP1 infection_NN1 for_IF whites_NN2 compared_VVN to_II African_JJ Americans_NN2 increased_VVN_VVD ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   87 Furthermore , the stratified analyses indicate that the duration of injection and type of incarceration differs by race .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   87 Furthermore_RR ,_Y the_AT stratified_JJ analyses_NN2 indicate_VV0 that_CST the_AT duration_NN1 of_IO injection_NN1 and_CC type_NN1 of_IO incarceration_NN1 differs_VVZ by_II race_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   88 These differences may explain why HCV is higher among whites compared to African Americans in incarcerated populations , compared to the opposite effect in general populations .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   88 These_DD2 differences_NN2 may_VM explain_VVI why_RRQ HCV_NP1 is_VBZ higher_JJR among_II whites_NN2 compared_VVN to_II African_JJ Americans_NN2 in_II incarcerated_JJ@ populations_NN2 ,_Y compared_VVN to_II the_AT opposite_JJ effect_NN1 in_II_RR21 general_JJ_RR22 populations_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   89 That is , although a higher percentage of African Americans reported correctional facility stays compared to whites , whites who reported correctional facility stays had a higher prevalence of HCV infection compared to African Americans , 96.0% versus 72.3% respectively .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   89 That_REX21 is_REX22 ,_Y although_CS a_AT1 higher_JJR percentage_NN1 of_IO African_JJ Americans_NN2 reported_VVD_VVN correctional_JJ facility_NN1 stays_NN2_VVZ compared_VVN to_II whites_NN2 ,_Y whites_NN2 who_PNQS reported_VVD correctional_JJ facility_NN1 stays_NN2 had_VHD a_AT1 higher_JJR prevalence_NN1 of_IO HCV_NP1 infection_NN1 compared_VVN to_II African_JJ Americans_NN2 ,_Y 96.0%_FO versus_II 72.3%_FO respectively_RR ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   90 Whereas HCV infection was similar among whites and African Americans who reported greater than five years of injection drug use ( 84.2 versus 83.5 , respectively ) , HCV infection was greater in whites compared to African American who reported less than 1 respectively ) , and who reported one to five years of injection drug use ( 64.3 versus 47.4 , respectively ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   90 Whereas_CS HCV_NP1 infection_NN1 was_VBDZ similar_JJ among_II whites_NN2 and_CC African_JJ Americans_NN2 who_PNQS reported_VVD greater_JJR than_CSN five_MC years_NNT2 of_IO injection_NN1 drug_NN1 use_NN1 (_Y 84.2_MC versus_II 83.5_MC ,_Y respectively_RR )_Y ,_Y HCV_NP1 infection_NN1 was_VBDZ greater_JJR in_II whites_NN2 compared_VVN to_II African_JJ American_NN1@ who_PNQS reported_VVD less_DAR_RRR than_CSN 1_MC1 respectively_RR )_Y ,_Y and_CC who_PNQS reported_VVD one_MC1 to_II five_MC years_NNT2 of_IO injection_NN1 drug_NN1 use_NN1 (_Y 64.3_MC versus_II 47.4_MC ,_Y respectively_RR )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   91 Further studies need to delineate why HCV rates are higher among incarcerated whites who report fewer years of injection drug use compared to incarcerated African Americans .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   91 Further_JJR studies_NN2 need_VV0 to_TO delineate_VVI why_RRQ HCV_NP1 rates_NN2 are_VBR higher_JJR among_II incarcerated_JJ@ whites_NN2 who_PNQS report_VV0@ fewer_DAR years_NNT2 of_IO injection_NN1 drug_NN1 use_NN1 compared_VVN to_II incarcerated_JJ@ African_JJ Americans_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   92 That is , future studies may want to control for not only the duration of injection drug use but also the frequency of use and high-risk injection drug use practices ( e.g. , sharing needles , backloading , etc .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   92 That_REX21 is_REX22 ,_Y future_JJ_NN1 studies_NN2 may_VM want_VVI to_TO control_VVI for_IF not_XX only_RR the_AT duration_NN1 of_IO injection_NN1 drug_NN1 use_NN1 but_CCB also_RR the_AT frequency_NN1 of_IO use_NN1 and_CC high-risk_JJ injection_NN1 drug_NN1 use_NN1_VV0 practices_NN2 (_Y e.g._REX ,_Y sharing_VVG needles_NN2 ,_Y backloading_VVG ,_Y etc_RA ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   93 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   93 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   94 Further , exploration of risk factors for HCV other than injection drug use , such as sexual risk factors , may need to be delineated by race .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   94 Further_RRR_JJR ,_Y exploration_NN1 of_IO risk_NN1 factors_NN2 for_IF HCV_NP1 other_II21 than_II22 injection_NN1 drug_NN1 use_NN1_VV0 ,_Y such_II21 as_II22 sexual_JJ risk_NN1 factors_NN2 ,_Y may_VM need_VVI to_TO be_VBI delineated_VVN by_II race_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   95 Given research conducted in the general population that has shown African Americans to be at greater risk to contract HCV than whites , the higher prevalence of HCV among incarcerated whites than among incarcerated African Americans is noteworthy .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   95 Given_VVN research_NN1 conducted_VVN_VVD in_II the_AT general_JJ_NN1 population_NN1 that_CST_DD1 has_VHZ shown_VVN African_JJ Americans_NN2 to_TO be_VBI at_II greater_JJR risk_NN1 to_TO contract_VVI HCV_NP1 than_CSN whites_NN2 ,_Y the_AT higher_JJR prevalence_NN1 of_IO HCV_NP1 among_II incarcerated_JJ@ whites_NN2 than_CSN among_II incarcerated_JJ@ African_JJ Americans_NN2 is_VBZ noteworthy_JJ ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   96 The differing base rates of incarceration among African Americans and whites in the United States could be a further explanation for this finding .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   96 The_AT differing_JJ base_NN1 rates_NN2 of_IO incarceration_NN1 among_II African_JJ Americans_NN2 and_CC whites_NN2_VVZ@ in_II the_AT United_NP1 States_NP1 could_VM be_VBI a_AT1 further_JJR@ explanation_NN1 for_IF this_DD1 finding_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   97 It is well documented that the U.S. incarcerates a 8 times that of other industrialized nations ( Harrison , 2003 ; Thomas Sampson , 2005 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   97 It_PPH1 is_VBZ well_RR documented_VVN_VVD that_CST the_AT U.S._NP1 incarcerates_VVZ a_AT1 8_MC times_NNT2 that_DD1 of_IO other_JJ industrialized_JJ nations_NN2 (_Y Harrison_NP1 ,_Y 2003_MC ;_Y Thomas_NP1 Sampson_NP1 ,_Y 2005_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   98 The rate of incarceration in the United States has increased by more-than 200% during the past 20 years , attributable mainly to a growth in the prosecution of drug-related offenses ( Macalino et al. , 2005 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   98 The_AT rate_NN1 of_IO incarceration_NN1 in_II the_AT United_NP1 States_NP1 has_VHZ increased_VVN by_II more-than_CSN 200%_NNU during_II the_AT past_JJ 20_MC years_NNT2 ,_Y attributable_JJ mainly_RR to_II a_AT1 growth_NN1 in_II the_AT prosecution_NN1 of_IO drug-related_JJ_NN1 offenses_NN2 (_Y Macalino_NP1 et_RA21 al._RA22 ,_Y 2005_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0   99 Further , while African Americans comprise 12.3% of the population , they comprise 43.7% of incarcerated individuals ( Bonczar Beck , 1997 ; Braithwaite Arriola , 2003 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0   99 Further_RRR_JJR ,_Y while_CS African_JJ Americans_NN2 comprise_VV0 12.3%_FO of_IO the_AT population_NN1 ,_Y they_PPHS2 comprise_VV0 43.7%_FO of_IO incarcerated_JJ@ individuals_NN2 (_Y Bonczar_NP1 Beck_NP1 ,_Y 1997_MC ;_Y Braithwaite_NP1 Arriola_NP1 ,_Y 2003_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  100 Equally alarming is the one-in-eight rate of incarceration among African American males aged 25-29 years ( Bonczar Beck , 1997 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  100 Equally_RR alarming_JJ_VVG@ is_VBZ the_AT one-in-eight_MC rate_NN1 of_IO incarceration_NN1 among_II African_JJ American_JJ males_NN2 aged_VVN_II@_VVD@ 25-29_MCMC years_NNT2 (_Y Bonczar_NP1 Beck_NP1 ,_Y 1997_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  101 To the extent that incarceration is less likely for whites than African Americans for drug-related offenses , whites who serve sentences may have higher levels of drug use , infectious disease , and pathology than incarcerated African Americans .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  101 To_II the_AT extent_NN1 that_CST_DD1 incarceration_NN1 is_VBZ less_RGR likely_JJ for_IF whites_NN2 than_CSN African_JJ Americans_NN2 for_IF drug-related_JJ_NN1 offenses_NN2_VVZ ,_Y whites_NN2 who_PNQS serve_VV0 sentences_NN2 may_VM have_VHI higher_JJR levels_NN2 of_IO drug_NN1 use_NN1_VV0 ,_Y infectious_JJ disease_NN1 ,_Y and_CC pathology_NN1 than_CSN incarcerated_JJ@_VVD_VVN@ African_JJ Americans_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  102 The stratified findings also have relevance to the prevention of HCV among African American and white populations of drug users .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  102 The_AT stratified_JJ findings_NN2 also_RR have_VH0 relevance_NN1 to_II the_AT prevention_NN1 of_IO HCV_NP1 among_II African_JJ American_JJ_NN1@ and_CC white_JJ populations_NN2 of_IO drug_NN1 users_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  103 Consistent with extant studies , longer duration of injection drug use was associated with HCV prevalence among African Americans and findings suggest the need for behavioral pharmacological interventions at each level of incarceration ( e.g. , from detentions and jails to prisons ) to reduce the use of illegal substances especially , IDU , which often involves sharing injection equipment among incarcerated populations .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  103 Consistent_JJ with_IW extant_JJ studies_NN2 ,_Y longer_JJR duration_NN1 of_IO injection_NN1 drug_NN1 use_NN1 was_VBDZ associated_VVN with_IW HCV_NP1 prevalence_NN1 among_II African_JJ Americans_NN2 and_CC findings_NN2 suggest_VV0 the_AT need_NN1 for_IF behavioral_JJ pharmacological_JJ interventions_NN2 at_II each_DD1 level_NN1 of_IO incarceration_NN1 (_Y e.g._REX ,_Y from_II detentions_NN2 and_CC jails_NN2 to_II prisons_NN2 )_Y to_TO reduce_VVI the_AT use_NN1 of_IO illegal_JJ substances_NN2 especially_RR ,_Y IDU_NP1_NN1 ,_Y which_DDQ often_RR involves_VVZ sharing_VVG_JJ@ injection_NN1 equipment_NN1 among_II incarcerated_JJ@ populations_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  104 Consideration of several limitations of this study is now discussed .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  104 Consideration_NN1 of_IO several_DA2 limitations_NN2 of_IO this_DD1 study_NN1 is_VBZ now_RT discussed_VVN ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  105 Notably , despite being of comparable size to several studies of adult injection drug users , this sample was relatively small , particularly with respect to the stratified analysis for some variables .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  105 Notably_RR ,_Y despite_II being_VBG of_IO comparable_JJ size_NN1 to_II several_DA2 studies_NN2 of_IO adult_NN1_JJ@ injection_NN1 drug_NN1 users_NN2 ,_Y this_DD1 sample_NN1 was_VBDZ relatively_RR small_JJ ,_Y particularly_RR with_II31 respect_II32 to_II33 the_AT stratified_JJ analysis_NN1 for_IF some_DD variables_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  106 Additionally , sufficient representation of ethnic/racial groups other than African American and white in the study sample did not allow for generalization to other ethnicity groups .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  106 Additionally_RR ,_Y sufficient_JJ representation_NN1 of_IO ethnic/racial_JJ groups_NN2 other_II21 than_II22 African_JJ American_JJ_NN1@ and_CC white_JJ_NN1@ in_II the_AT study_NN1 sample_NN1 did_VDD not_XX allow_VVI for_IF generalization_NN1 to_II other_JJ ethnicity_NN1 groups_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  107 Further , the cross-sectional data utilized in the present study limits the capacity to infer causal relationships .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  107 Further_RRR_JJR ,_Y the_AT cross-sectional_JJ data_NN utilized_VVN_VVD in_II the_AT present_JJ_NN1 study_NN1 limits_VVZ the_AT capacity_NN1 to_TO infer_VVI causal_JJ relationships_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  108 Future studies will need to evaluate the present study findings in light of incidence data that provide a more precise measure of the nature of an epidemic .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  108 Future_JJ_NN1 studies_NN2 will_VM need_VVI to_TO evaluate_VVI the_AT present_JJ_NN1 study_NN1 findings_NN2 in_II31 light_II32 of_II33 incidence_NN1 data_NN that_CST provide_VV0 a_AT1 more_RGR precise_JJ measure_NN1 of_IO the_AT nature_NN1 of_IO an_AT1 epidemic_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  109 Despite these important limitations , the present study design and sampling method provide contributions to the HCV literature , particularly with respect to insights into possible foci of prevention programs throughout the United States do not incorporate systematic HCV screening or prevention programs for inmates ( Braithwaite Arriola , 2003 ; Hammett et al. , 2002 ) .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  109 Despite_II these_DD2 important_JJ limitations_NN2 ,_Y the_AT present_JJ_NN1 study_NN1 design_NN1 and_CC sampling_VVG_NN1 method_NN1 provide_VV0 contributions_NN2 to_II the_AT HCV_NP1 literature_NN1 ,_Y particularly_RR with_II31 respect_II32 to_II33 insights_NN2 into_II possible_JJ foci_NN2 of_IO prevention_NN1 programs_NN2 throughout_II the_AT United_NP1 States_NP1 do_VD0 not_XX incorporate_VVI systematic_JJ HCV_NP1 screening_NN1_VVG or_CC prevention_NN1 programs_NN2 for_IF inmates_NN2 (_Y Braithwaite_NP1 Arriola_NP1 ,_Y 2003_MC ;_Y Hammett_NP1 et_RA21 al._RA22 ,_Y 2002_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  110 A growing base of empirical research strongly suggests that the absence of such programming represents a lost opportunity to improve public health within society as a whole as well as among inmates and those released from incarceration .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  110 A_AT1_ZZ1 growing_JJ base_NN1 of_IO empirical_JJ research_NN1 strongly_RR suggests_VVZ that_CST the_AT absence_NN1 of_IO such_DA programming_NN1 represents_VVZ a_AT1 lost_JJ@ opportunity_NN1 to_TO improve_VVI public_JJ_NN1 health_NN1 within_II society_NN1 as_II a_AT1 whole_NN1 as_II31_RG well_II32_RR as_II33_CSA among_II inmates_NN2 and_CC those_DD2 released_VVN from_II incarceration_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  111 When an estimated 30% to 90% of drug users with a history of incarceration are seropositive for HCV , the utility of providing systematic screening and prevention efforts within jails and correctional facilities is clear .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  111 When_CS an_AT1 estimated_JJ@ 30%_NNU to_II 90%_NNU of_IO drug_NN1 users_NN2 with_IW a_AT1 history_NN1 of_IO incarceration_NN1 are_VBR seropositive_JJ for_IF HCV_NP1 ,_Y the_AT utility_NN1 of_IO providing_VVG systematic_JJ screening_NN1 and_CC prevention_NN1 efforts_NN2 within_II jails_NN2 and_CC correctional_JJ facilities_NN2 is_VBZ clear_JJ ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  112 The significance of such programming for the prevention of subsequent HCV transmission in the general population is necessary when considered in light of the estimated 7 million inmates released from jails or correctional institutions annually .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  112 The_AT significance_NN1 of_IO such_DA programming_NN1 for_IF the_AT prevention_NN1 of_IO subsequent_JJ HCV_NP1 transmission_NN1 in_II the_AT general_JJ_NN1 population_NN1 is_VBZ necessary_JJ when_CS considered_VVN in_II31 light_II32 of_II33 the_AT estimated_JJ@ 7_MC million_M1 inmates_NN2 released_VVN from_II jails_NN2 or_CC correctional_JJ institutions_NN2 annually_RR ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  113 ACKNOWLEDGEMENT The authors would like to thank the study staff and participants and Dr. David Celentano for project consultation .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  113 ACKNOWLEDGEMENT_NN1 The_AT authors_NN2 would_VM like_VVI to_TO thank_VVI the_AT study_NN1 staff_NN and_CC participants_NN2 and_CC Dr._NNB David_NP1 Celentano_NP1_NN1 for_IF project_NN1 consultation_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  114 This research was made possible with support from NIDA ( R01 DA014498 ) and NIDA Training Program ( T32DA007292 ) for S. Geoffrey Severtson .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  114 This_DD1 research_NN1 was_VBDZ made_VVN possible_JJ with_IW support_NN1 from_II NIDA_NP1_NN1 (_Y R01_FO DA014498_FO )_Y and_CC NIDA_NP1_NN1 Training_NN1 Program_NN1 (_Y T32DA007292_FO )_Y for_IF S._ZZ Geoffrey_NP1 Severtson_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  115 Table 1 : Associations of HCV Infection Alter , M.J. 1997 Epidemiology of hepatitis C. Hepatology , 26(S3) , 62S-65S .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  115 Table_NN1_VV0% 1_MC1 :_Y Associations_NN2 of_IO HCV_NP1 Infection_NN1 Alter_VV0 ,_Y M.J._NP1 1997_MC Epidemiology_NN1 of_IO hepatitis_NN1 C._NP1 Hepatology_NP1 ,_Y 26(S3)_FO ,_Y 62S-65S_MC2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  116 Alter , M.J. , Mast , E.E .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  116 Alter_VV0 ,_Y M.J._NP1 ,_Y Mast_NN1 ,_Y E.E_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  117 1994 The epidemiology of viral hepatitis in the United States .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  117 1994_MC The_AT epidemiology_NN1 of_IO viral_JJ hepatitis_NN1 in_II the_AT United_NP1 States_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  118 Gastroenterology Clinics of North America , 23(3) , 437-455 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  118 Gastroenterology_NN1_NP1@ Clinics_NN2 of_IO North_ND1 America_NP1 ,_Y 23(3)_FO ,_Y 437-455_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  119 Baillargeon , J. , Wu , H. , Kelley , M.J. , Grady , J. , Linthicum , L. , Dunn , K. 2003 Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  119 Baillargeon_NN1_NP1@ ,_Y J._NP1 ,_Y Wu_NP1_NN1 ,_Y H._NP1 ,_Y Kelley_NP1_NN1 ,_Y M.J._NP1 ,_Y Grady_NP1_NN1 ,_Y J._NP1 ,_Y Linthicum_NP1_NN1 ,_Y L._ZZ ,_Y Dunn_NP1 ,_Y K._NP1 2003_MC Hepatitis_NP1 C_NP1_ZZ1 seroprevalence_NN1 among_II newly_RR incarcerated_VVD_JJ@ inmates_NN2 in_II the_AT Texas_NP1 correctional_JJ system_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  120 Public Health , 117(1) , 43-48 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  120 Public_JJ_NN1 Health_NN1 ,_Y 117(1)_FO ,_Y 43-48_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  121 Bonczar , T.P. , Beck , A.J. 1997 Lifetime likelihood of going to state or federal prison .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  121 Bonczar_VV0_NN1_NP1@ ,_Y T.P._NP1 ,_Y Beck_NP1 ,_Y A.J._NP1 1997_MC Lifetime_NNT1 likelihood_NN1 of_IO going_VVGK to_TO state_VVI or_CC federal_JJ prison_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  122 Washington , DC : Bureau of Justice Statistics .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  122 Washington_NP1 ,_Y DC_NP1 :_Y Bureau_NN1 of_IO Justice_NN1 Statistics_NN ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  123 Braithwaite , R.L. , Arriola , K.R. 2003 Male prisoners and HIV prevention : A call for action ignored .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  123 Braithwaite_NP1 ,_Y R.L._NP1 ,_Y Arriola_NP1 ,_Y K.R._NP1 2003_MC Male_JJ prisoners_NN2 and_CC HIV_NP1 prevention_NN1 :_Y A_ZZ1_AT1@ call_VV0_NN1 for_IF action_NN1 ignored_VVD_VVN ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  124 American Journal of Public Health , 93(5) , 759-763 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  124 American_JJ Journal_NN1 of_IO Public_JJ_NN1 Health_NN1 ,_Y 93(5)_FO ,_Y 759-763_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  125 Centers for Disease Control 2008 Viral hepatitis C : Fact sheet , http : **50;22798;TOOLONG .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  125 Centers_NN2 for_IF Disease_NN1 Control_NN1 2008_MC Viral_JJ hepatitis_NN1 C_NP1_ZZ1 :_Y Fact_NN1 sheet_NN1 ,_Y http_NNU :_Y **50;22798;TOOLONG_FU ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  126 Fleckenstein , J. 2004 Chronic hepatitis C in African Americans and other minority groups .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  126 Fleckenstein_NN1_NP1@ ,_Y J._NP1 2004_MC Chronic_JJ hepatitis_NN1 C_ZZ1_NP1 in_II African_JJ Americans_NN2 and_CC other_JJ minority_NN1 groups_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  127 Current Gastroenterolology Reports , 6(1) , 66-70 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  127 Current_JJ Gastroenterolology_NN1 Reports_NN2_VVZ ,_Y 6(1)_FO ,_Y 66-70_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  128 Galeazzi , B. , , F. 1995 Hepatitis C virus infection in Italian intravenous drug users : Epidemiological and clinical aspects .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  128 Galeazzi_NN2_NP1@ ,_Y B._NP1 ,_Y ,_Y F._NP1_RA@ 1995_MC Hepatitis_NP1 C_NP1_ZZ1 virus_NN1 infection_NN1 in_II Italian_JJ intravenous_JJ drug_NN1 users_NN2 :_Y Epidemiological_NP1_JJ and_CC clinical_JJ aspects_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  129 Liver , 15(4) , 209-212 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  129 Liver_NN1 ,_Y 15(4)_FO ,_Y 209-212_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  130 Garfein , R.S. , Vlahov , D. , Galai , N. , Doherty , M.C. , Nelson , K.E. 1996 Viral infections in short-term injection drug users : The prevalence of the hepatitis C , hepatitis B , human immunodeficiency , and human T-lymphotropic viruses .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  130 Garfein_NN1_NP1@ ,_Y R.S._NN1 ,_Y Vlahov_NP1 ,_Y D._NP1 ,_Y Galai_NP1_NN1 ,_Y N._NP1_NNU ,_Y Doherty_NP1_NN1 ,_Y M.C._NN1 ,_Y Nelson_NP1 ,_Y K.E._NP1 1996_MC Viral_JJ infections_NN2 in_II short-term_JJ injection_NN1 drug_NN1 users_NN2 :_Y The_AT prevalence_NN1 of_IO the_AT hepatitis_NN1 C_ZZ1_NP1 ,_Y hepatitis_NN1 B_ZZ1 ,_Y human_JJ_NN1 immunodeficiency_NN1 ,_Y and_CC human_JJ T-lymphotropic_JJ viruses_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  131 American Journal of Public Health , 86(5) , 655-661 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  131 American_JJ Journal_NN1 of_IO Public_JJ_NN1 Health_NN1 ,_Y 86(5)_FO ,_Y 655-661_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  132 Hagan , H. , Des Jarlais , D.C. , Stern , R. , Lelutiu-Weinberger , C. , Scheinmann , R. , Strauss , S. , Flom , P.L. 2007 HCV synthesis project : Preliminary analyses of HCV prevalence in relation to age and duration of injection .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  132 Hagan_NN1_NP1@ ,_Y H._NP1 ,_Y Des_NP1_FW Jarlais_NP1_NN1 ,_Y D.C._NP1 ,_Y Stern_NN1_JJ ,_Y R._NP1 ,_Y Lelutiu-Weinberger_NP1 ,_Y C._NP1_ZZ1@ ,_Y Scheinmann_NP1 ,_Y R._NP1 ,_Y Strauss_NP1 ,_Y S._ZZ ,_Y Flom_NP1_VV0_NN1 ,_Y P.L._NP1_NN1 2007_MC HCV_NP1 synthesis_NN1 project_NN1 :_Y Preliminary_JJ analyses_NN2 of_IO HCV_NP1 prevalence_NN1 in_II31 relation_II32 to_II33 age_NN1 and_CC duration_NN1 of_IO injection_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  133 International Journal of Drug Policy , 18(5) , 341-51 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  133 International_JJ Journal_NN1 of_IO Drug_NN1 Policy_NN1 ,_Y 18(5)_FO ,_Y 341-51_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  134 Epub 2007 May 2 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  134 Epub_VV0_NN1 2007_MC May_NPM1 2_MC ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  135 Hammett , T.M. , Harmon , M.P. , Rhodes , W. 2002 The burden of infectious disease among inmates of and releasees from US correctional facilities , 1997 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  135 Hammett_VV0_NN1_NP1@ ,_Y T.M._NP1 ,_Y Harmon_NP1_NN1 ,_Y M.P._NNA ,_Y Rhodes_NP1 ,_Y W._NP1 2002_MC The_AT burden_NN1 of_IO infectious_JJ disease_NN1 among_II inmates_NN2 of_IO and_CC releasees_NN2 from_II US_NP1_PPIO2@ correctional_JJ facilities_NN2 ,_Y 1997_MC ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  136 American Journal of Public Health , 92(11) , 1789-1794 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  136 American_JJ Journal_NN1 of_IO Public_JJ_NN1 Health_NN1 ,_Y 92(11)_FO ,_Y 1789-1794_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  137 Harrison , P.M. , K.J. 2003 Prison : Bureau of Justice Statistics .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  137 Harrison_NP1 ,_Y P.M._RA_NP1 ,_Y K.J._NP1 2003_MC Prison_NN1 :_Y Bureau_NN1 of_IO Justice_NN1 Statistics_NN ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  138 Macalino , G.E. , Vlahov , D. , Dickinson , B.P. , Schwartzapfel , B. , Rich , J.D. 2005 Community incidence of hepatitis B and C among reincarcerated women .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  138 Macalino_NP1 ,_Y G.E._NP1 ,_Y Vlahov_NP1 ,_Y D._NP1 ,_Y Dickinson_NP1 ,_Y B.P._NP1 ,_Y Schwartzapfel_NP1 ,_Y B._NP1 ,_Y Rich_JJ_NP1@ ,_Y J.D._NP1 2005_MC Community_NN1 incidence_NN1 of_IO hepatitis_NN1 B_ZZ1 and_CC C_ZZ1_NP1 among_II reincarcerated_JJ@ women_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  139 Clinical Infectious Disease , 41(7) , 998-1002 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  139 Clinical_JJ Infectious_JJ Disease_NN1 ,_Y 41(7)_FO ,_Y 998-1002_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  140 Macalino , G.E. , Vlahov , D. , Sanford-Colby , S. , Patel , S. , Sabin , K. , Salas , C. , Rich , J.D. 2004 Prevalence and incidence of HIV , hepatitis B virus , and hepatitis C virus infections among males in Rhode Island prisons .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  140 Macalino_NP1 ,_Y G.E._NP1 ,_Y Vlahov_NP1 ,_Y D._NP1 ,_Y Sanford-Colby_NP1 ,_Y S._ZZ ,_Y Patel_NP1 ,_Y S._ZZ ,_Y Sabin_NP1 ,_Y K._NP1 ,_Y Salas_NP2_NN2@ ,_Y C._NP1_ZZ1@ ,_Y Rich_JJ_NP1@ ,_Y J.D._NP1 2004_MC Prevalence_NP1 and_CC incidence_NN1 of_IO HIV_NP1 ,_Y hepatitis_NN1 B_ZZ1 virus_NN1 ,_Y and_CC hepatitis_NN1 C_ZZ1_NP1 virus_NN1 infections_NN2 among_II males_NN2 in_II Rhode_NP1 Island_NNL1 prisons_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  141 American Journal of Public Health , 94(7) , 1218-1223 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  141 American_JJ Journal_NN1 of_IO Public_JJ_NN1 Health_NN1 ,_Y 94(7)_FO ,_Y 1218-1223_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  142 Pyrsopoulos , N. , Jeffers , L. 2007 Hepatitis C in African Americans .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  142 Pyrsopoulos_NN2_NP1@ ,_Y N._NP1_NNU ,_Y Jeffers_NP1 ,_Y L._ZZ 2007_MC Hepatitis_NP1 C_NP1_ZZ1 in_II African_JJ Americans_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  143 Journal of Clinical Gastroenterology , 41(2) , 185-193 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  143 Journal_NN1 of_IO Clinical_JJ Gastroenterology_NN1_NP1 ,_Y 41(2)_FO ,_Y 185-193_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  144 Rawls , R.A. , Vega , K.J. 2005 Viral hepatitis in minority America .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  144 Rawls_NP1 ,_Y R.A._NNA ,_Y Vega_NP1 ,_Y K.J._NP1 2005_MC Viral_JJ hepatitis_NN1 in_II minority_NN1 America_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  145 Journal of Clinical Gastroenterology , 39(2) , 144-151 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  145 Journal_NN1 of_IO Clinical_JJ Gastroenterology_NN1_NP1 ,_Y 39(2)_FO ,_Y 144-151_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  146 Reindollar , R.W. 1999 Hepatitis C and the correctional population .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  146 Reindollar_NP1@_JJ ,_Y R.W._NP1 1999_MC Hepatitis_NP1_NN1 C_NP1_ZZ1 and_CC the_AT correctional_JJ population_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  147 The American Journal of Medicine , 107(6B) , 100S-103S .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  147 The_AT American_JJ Journal_NN1 of_IO Medicine_NN1 ,_Y 107(6B)_FO ,_Y 100S-103S_MC2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  148 Ruiz , J.D. , Molitor , F. , Sun , R.K. , Mikanda , J. , G.W. , Jr. , Ascher , M.S. 1999 Prevalence and correlates of hepatitis C virus infection among inmates entering the California correctional system .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  148 Ruiz_VV0_NN1_NP1@ ,_Y J.D._NP1 ,_Y Molitor_NP1_NN1 ,_Y F._NP1_RA@ ,_Y Sun_NN1 ,_Y R.K._NP1 ,_Y Mikanda_NP1 ,_Y J._NP1 ,_Y G.W._NP1 ,_Y Jr._NP1 ,_Y Ascher_NP1_NN1 ,_Y M.S._NN1_NNB 1999_MC Prevalence_NP1 and_CC correlates_NN2@_VVZ of_IO hepatitis_NN1 C_ZZ1_NP1 virus_NN1 infection_NN1 among_II inmates_NN2 entering_VVG the_AT California_NP1 correctional_JJ system_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  149 The Western Journal of Medicine , 170(3) , 156-160 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  149 The_AT Western_JJ Journal_NN1 of_IO Medicine_NN1 ,_Y 170(3)_FO ,_Y 156-160_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  150 SAS 9.1 2002-03 Cary , NC , USA : SAS Institute Inc .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  150 SAS_NP1 9.1_MC 2002-03_MCMC Cary_NP1 ,_Y NC_NP1 ,_Y USA_NP1 :_Y SAS_NP1 Institute_NN1 Inc_JJ ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  151 Solomon , L. , Flynn , C. , Muck , K. , Vertefeuille , J. 2004 Prevalence of HIV , syphilis , hepatitis B , and hepatitis C among entrants to Maryland correctional facilities .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  151 Solomon_NP1 ,_Y L._ZZ ,_Y Flynn_NP1 ,_Y C._NP1_ZZ1@ ,_Y Muck_NN1 ,_Y K._NP1 ,_Y Vertefeuille_NP1 ,_Y J._NP1 2004_MC Prevalence_NN1@_NP1 of_IO HIV_NP1 ,_Y syphilis_NN1 ,_Y hepatitis_NN1 B_ZZ1 ,_Y and_CC hepatitis_NN1 C_ZZ1_NP1 among_II entrants_NN2 to_II Maryland_NP1 correctional_JJ facilities_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  152 Journal of Urban Health , 81(1) , 25-37 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  152 Journal_NN1 of_IO Urban_JJ Health_NN1 ,_Y 81(1)_FO ,_Y 25-37_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  153 Strathdee , S.A. , Sherman , S.G. 2003 The role of sexual transmission of HIV infection among injection and non-injection-drug users .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  153 Strathdee_NN1_NP1@ ,_Y S.A._NP1 ,_Y Sherman_NP1 ,_Y S.G._NP1 2003_MC The_AT role_NN1 of_IO sexual_JJ transmission_NN1 of_IO HIV_NP1 infection_NN1 among_II injection_NN1 and_CC non-injection-drug_JJ_NN1 users_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  154 Journal of Urban Health , 80 ( 4 , Suppl. 3 ) , iii7-iii14 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  154 Journal_NN1 of_IO Urban_JJ Health_NN1 ,_Y 80_NN1_VV0_JJ (_Y 4_VV0_NN1_JJ ,_Y Suppl._NP1 3_MC )_Y ,_Y iii7-iii14_NN1_JJ ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  155 Thomas , J.C. , Sampson , L.A. 2005 High rates of incarceration as a social force associated with community rates of sexually transmitted infection .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  155 Thomas_NP1 ,_Y J.C._NP1 ,_Y Sampson_NP1 ,_Y L.A._NP1 2005_MC High_JJ rates_NN2 of_IO incarceration_NN1 as_II_CSA a_AT1 social_JJ force_NN1 associated_VVN with_IW community_NN1 rates_NN2 of_IO sexually_RR transmitted_JJ_VVN infection_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  156 The Journal of Infectious Diseases , 191 ( Suppl. 1 ) , S55-S60 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  156 The_AT Journal_NN1 of_IO Infectious_JJ Diseases_NN2 ,_Y 191_NN1_VV0_JJ (_Y Suppl._NP1 1_MC1 )_Y ,_Y S55-S60_NN1_JJ ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  157 Vlahov , D. , Nelson , K.E. , Quinn , T.C. , Kendig , N. 1993 Prevalence and in Maryland .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  157 Vlahov_NP1 ,_Y D._NP1 ,_Y Nelson_NP1 ,_Y K.E._NP1 ,_Y Quinn_NP1 ,_Y T.C._NP1 ,_Y Kendig_NP1_VV0_NN1 ,_Y N._NP1_NNU 1993_MC Prevalence_NP1 and_CC in_II Maryland_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  158 European Journal Epidemiology , 9(5) , 566-569 .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  158 European_JJ Journal_NN1 Epidemiology_NN1_NP1 ,_Y 9(5)_FO ,_Y 566-569_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  159 By William W. Latimer ; Sarra L. Hedden ; Leah Floyd ; April Lawson ; Alexander Melnikov ; S. Geoffrey Severtson ; Anne-Gloria Moleko and Kristin Cole Dr. Latimer , Dr. Hedden , Dr. Floyd , Ms. Lawson , Mr. Melnikov and Mr. Severtson are with the Department of Mental Health , Johns Hopkins University Bloomberg School of Public Health , Baltimore , Maryland .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  159 By_II William_NP1 W._NP1 Latimer_NP1 ;_Y Sarra_NP1 L._ZZ Hedden_NP1_NN1 ;_Y Leah_NP1 Floyd_NP1 ;_Y April_NPM1_NP1% Lawson_NP1 ;_Y Alexander_NP1 Melnikov_NP1 ;_Y S._ZZ Geoffrey_NP1 Severtson_NP1 ;_Y Anne-Gloria_NP1 Moleko_NP1_NN1 and_CC Kristin_NP1 Cole_NP1 Dr._NNB Latimer_NP1 ,_Y Dr._NNB Hedden_NP1 ,_Y Dr._NNB Floyd_NP1 ,_Y Ms._NNB Lawson_NP1 ,_Y Mr._NNB Melnikov_NP1 and_CC Mr._NNB Severtson_NP1 are_VBR with_IW the_AT Department_NN1 of_IO Mental_JJ Health_NN1 ,_Y Johns_NP1 Hopkins_NP1 University_NN1 Bloomberg_NP1 School_NN1 of_IO Public_JJ_NN1 Health_NN1 ,_Y Baltimore_NP1 ,_Y Maryland_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  160 Dr. Anne-Gloria Moleko is with the Department of Human Sciences , University of Pretoria , Pretoria , South Africa .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  160 Dr._NNB Anne-Gloria_NP1 Moleko_NP1_NN1 is_VBZ with_IW the_AT Department_NN1 of_IO Human_JJ_NN1 Sciences_NN2 ,_Y University_NN1 of_IO Pretoria_NP1 ,_Y Pretoria_NP1 ,_Y South_NP1 Africa_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  161 Kristin Cole , M.S.W. , is with the Columbia University School of Social Work , New York , New York .
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  161 Kristin_NP1@ Cole_NP1 ,_Y M.S.W._NP1 ,_Y is_VBZ with_IW the_AT Columbia_NP1 University_NN1 School_NN1 of_IO Social_JJ Work_NN1 ,_Y New_NP1 York_NP1 ,_Y New_NP1 York_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  A    0  162 
SENTPOS COCA_acad_wlp_2009_07_FILE##4079996 COCA  B    0  162 
